These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31978114)

  • 1. Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme.
    Bergkvist L; Richards DR; Bernardo-Gancedo A; Kumita JR; Nilsson PR; Brorsson AC
    PLoS One; 2020; 15(1):e0227227. PubMed ID: 31978114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Amyloid P Component Ameliorates Neurological Damage Caused by Expressing a Lysozyme Variant in the Central Nervous System of Drosophila melanogaster.
    Helmfors L; Bergkvist L; Brorsson AC
    PLoS One; 2016; 11(7):e0159294. PubMed ID: 27428539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of TTR aggregation-induced cell death--a new role for serum amyloid P component.
    Andersson K; Pokrzywa M; Dacklin I; Lundgren E
    PLoS One; 2013; 8(2):e55766. PubMed ID: 23390551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster.
    Kumita JR; Helmfors L; Williams J; Luheshi LM; Menzer L; Dumoulin M; Lomas DA; Crowther DC; Dobson CM; Brorsson AC
    FASEB J; 2012 Jan; 26(1):192-202. PubMed ID: 21965601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary renal amyloidosis associated with variant lysozyme in a large English family.
    Gillmore JD; Booth DR; Madhoo S; Pepys MB; Hawkins PN
    Nephrol Dial Transplant; 1999 Nov; 14(11):2639-44. PubMed ID: 10534505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of fibrillogenesis and the protective role of amyloid P component: two possible avenues for therapy.
    Pepys MB; Tennent GA; Booth DR; Bellotti V; Lovat LB; Tan SY; Persey MR; Hutchinson WL; Booth SE; Madhoo S; Soutar AK; Hawkins PN; Van Zyl-Smit R; Campistol JM; Fraser PE; Radford SE; Robinson CV; Sunde M; Serpell LC; Blake CC
    Ciba Found Symp; 1996; 199():73-81; discussion 81-9. PubMed ID: 8915605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.
    Pepys MB
    Front Immunol; 2018; 9():2382. PubMed ID: 30459761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation.
    Ziaunys M; Sakalauskas A; Sneideris T; Smirnovas V
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33579016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lysozyme amyloidogenesis by phospholipids. Focus on long-chain dimyristoylphosphocholine.
    Ponikova S; Kubackova J; Bednarikova Z; Marek J; Demjen E; Antosova A; Musatov A; Gazova Z
    Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2934-2943. PubMed ID: 28865760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.
    Ozawa D; Nomura R; Mangione PP; Hasegawa K; Okoshi T; Porcari R; Bellotti V; Naiki H
    Sci Rep; 2016 Jul; 6():29077. PubMed ID: 27380955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster.
    Sandin L; Bergkvist L; Nath S; Kielkopf C; Janefjord C; Helmfors L; Zetterberg H; Blennow K; Li H; Nilsberth C; Garner B; Brorsson AC; Kågedal K
    FEBS J; 2016 Oct; 283(19):3508-3522. PubMed ID: 27562772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of experimental murine AA amyloid fibrils in SAP-deficient mice: high resolution ultrastructural study.
    Inoue S; Kawano H; Ishihara T; Maeda S; Ohno S
    Amyloid; 2005 Sep; 12(3):157-63. PubMed ID: 16194870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous serum amyloid P component-deficiency does not enhance regression of AA amyloid deposits.
    Usui I; Kawano H; Ito S; Hamada Y; Ishihara T; Maeda S
    Amyloid; 2001 Jun; 8(2):101-4. PubMed ID: 11409030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants.
    Morozova-Roche LA; Zurdo J; Spencer A; Noppe W; Receveur V; Archer DB; Joniau M; Dobson CM
    J Struct Biol; 2000 Jun; 130(2-3):339-51. PubMed ID: 10940237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the effects of methylene blue on amyloid fibrillogenesis of lysozyme.
    How SC; Cheng YH; Lo CH; Lai JT; Lin TH; Bednarikova Z; Antosova A; Gazova Z; Wu JW; Wang SS
    Int J Biol Macromol; 2018 Nov; 119():1059-1067. PubMed ID: 30099040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of rapid coaggregation of globular proteins during amyloid formation.
    Dubey K; Anand BG; Temgire MK; Kar K
    Biochemistry; 2014 Dec; 53(51):8001-4. PubMed ID: 25494036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipids uniquely alter secondary structure and toxicity of lysozyme aggregates.
    Matveyenka M; Zhaliazka K; Rizevsky S; Kurouski D
    FASEB J; 2022 Oct; 36(10):e22543. PubMed ID: 36094052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis.
    Moderer T; Puşcalău-Gîrţu I; Haupt C; Baur J; Rodríguez-Alfonso A; Wiese S; Schmidt CQ; Malešević M; Forssmann WG; Ständker L; Fändrich M
    Amyloid; 2023 Dec; 30(4):424-433. PubMed ID: 37431668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serum amyloid P component for systemic amyloidosis in transgenic mice carrying human mutant transthyretin gene.
    Tashiro F; Yi S; Wakasugi S; Maeda S; Shimada K; Yamamura K
    Gerontology; 1991; 37 Suppl 1():56-62. PubMed ID: 1937069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.